Product NDC: | 55390-170 |
Proprietary Name: | Lorazepam |
Non Proprietary Name: | Lorazepam |
Active Ingredient(s): | 2 mg/mL & nbsp; Lorazepam |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-170 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077076 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060914 |
Package NDC: | 55390-170-10 |
Package Description: | 10 VIAL, MULTI-DOSE in 1 BOX (55390-170-10) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 55390-170-10 |
Proprietary Name | Lorazepam |
Package Description | 10 VIAL, MULTI-DOSE in 1 BOX (55390-170-10) > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 55390-170 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lorazepam |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20060914 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | LORAZEPAM |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |